The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery
NCT ID: NCT01450956
Last Updated: 2011-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2011-09-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sevoflurane
Patients will receive 2% sevoflurane via oxygenator during CPB
Sevoflurane
Sevoflurane will be given at a concentration of 2% through oxygenator during CPB
Control
Patients will receive only oxygen and air through oxygenator
Control
Patients will receive only oxygen and air through oxygenator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane
Sevoflurane will be given at a concentration of 2% through oxygenator during CPB
Control
Patients will receive only oxygen and air through oxygenator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosed with congenital heart diseases
* scheduled for repair operation with CPB
* in the Department of Cardiovascular Surgery, Xijing Hospital
Exclusion Criteria
* other systemic diseases
1 Month
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhenxiao Jin, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiovascular Surgery, Xijing Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiovascular Surgery, Xijing Hospital
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhenxiao Jin, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Xiong HY, Liu Y, Shu DC, Zhang SL, Qian X, Duan WX, Cheng L, Yu SQ, Jin ZX. Effects of Sevoflurane Inhalation During Cardiopulmonary Bypass on Pediatric Patients: A Randomized Controlled Clinical Trial. ASAIO J. 2016 Jan-Feb;62(1):63-8. doi: 10.1097/MAT.0000000000000285.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJXZ2011-010
Identifier Type: -
Identifier Source: org_study_id